Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | ELANE | P08246 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8821546 | 0.86 | ELANE (0.52) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL3959473 | 0.84 | MAPT (0.69) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL29551111 | 0.83 | MAPT (0.60) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL497339 | 0.83 | MAPT (0.60) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL20746507 | 0.83 | SMN1; SMN2 (0.49) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL11107245 | 0.83 | TTR (0.54) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL11101186 | 0.82 | TTR (0.72) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL28650516 | 0.82 | MAPK1 (0.47) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL27916746 | 0.82 | MAPT (0.57) | SMN1; SMN2NPC1RAB9ATTRMAPT | |
| SCHEMBL8386529 | 0.79 | SMN1; SMN2 (0.58) | SMN1; SMN2NPC1RAB9ATTRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320940-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-4194477-A1 | PHOTOCATIONIC CURABLE COMPOSITION AND CURABLE DENTAL COMPOSITION | Tokuyama Dental Corporation (JP) | 2023-06-14 | — | — | EP | disclosed |
| EP-1591098-B1 | Cationically curable composition for dental use | TOKUYAMA CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7365106-B2 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2008-04-29 | — | — | US | disclosed |
| EP-1431315-B1 | Photopolymerization initiator and photopolymerizable composition | TOKUYAMA CORP (JP) | 2007-10-17 | — | — | EP | disclosed |
| CN-1732883-A | Cationically curable composition for dental use | TOKUYAMA CORP (JP) | 2006-02-15 | — | — | CN | disclosed |
| US-20050250868-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1591098-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-20040186195-A1 | Photopolymerization initiator and photopolymerizable composition | TOKUYAMA CORPORATION (JP) | 2004-09-23 | — | — | US | disclosed |
| EP-1431315-A2 | Photopolymerization initiator and photopolymerizable composition | Tokuyama Corporation (JP) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320940-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION | CTH, GCLC, AAAS | SMN1; SMN2 3290/4885NPC1 4742/4885RAB9A 2337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.